Patents Assigned to SIMCERE BIO-PHARMACEUTICAL TECHNOLOGY., LTD.
  • Anti-TNFR2 antibody and use thereof
    Patent number: 12297284
    Abstract: Provided is an antibody or an antigen-binding fragment thereof capable of specifically binding to TNFR2, wherein the antibody or the antigen-binding fragment thereof is capable of regulating the function of immune cells and may be used as a medicament to treat diseases related to immune-related disorders, such as tumors. A polynucleotide encoding the antibody or antigen-binding fragment thereof and a pharmaceutical composition comprising the antibody or antigen binding fragment thereof are also provided.
    Type: Grant
    Filed: July 31, 2020
    Date of Patent: May 13, 2025
    Assignees: JIANGSU SIMCERE PHARMACEUTICAL CO., LTD., SIMCERE BIO-PHARMACEUTICAL TECHNOLOGY., LTD.
    Inventors: Xinyan Zhao, Xiaofeng Zhao, Shiqiang Lu, Ran Pang, Xinxin Li, Jinsheng Ren